Metraipolis › archive › dc_301aafe8d212

Targeting Middle East Respiratory Syndrome Coronavirus Spike Fusion Machinery With Antiviral Peptides: In Silico Exploration of the Heptad Repeat 2 Domain — Europe PMC PMID:42082899

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42082899
DOI
10.1002/mbo3.70299
License (as archived)
solo-consultazione
Archived
2026-10-31T23:24:45.150Z
SHA-256 of the archived text
63ff516bacdc0c1e0d73cae20d3e26f173b9942bb95a07bc0e5d41b0219f235e
Stable URL of this page
https://metraipolis.com/documento/dc_301aafe8d212

How to cite

Targeting Middle East Respiratory Syndrome Coronavirus Spike Fusion Machinery With Antiviral Peptides: In Silico Exploration of the Heptad Repeat 2 Domain — Europe PMC PMID:42082899 — Europe PMC (en), https://europepmc.org/article/MED/42082899 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_301aafe8d212 (Metraipolis archive dc_301aafe8d212, sha256 63ff516bacdc0c1e0d73cae20d3e26f173b9942bb95a07bc0e5d41b0219f235e)
BibTeX
@misc{dc301aafe8d212,
  title = {Targeting Middle East Respiratory Syndrome Coronavirus Spike Fusion Machinery With Antiviral Peptides: In Silico Exploration of the Heptad Repeat 2 Domain — Europe PMC PMID:42082899},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42082899},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_301aafe8d212; sha256 63ff516bacdc0c1e0d73cae20d3e26f173b9942bb95a07bc0e5d41b0219f235e},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42082899. Agents can read the archived copy with the MCP tool read_document.